Tonsil Cancer Treatment in China: Two Patient Journeys, Surgery, Radiotherapy and Costs

Explore two real tonsil cancer treatment journeys in China, including surgery, radiotherapy, side effects, treatment costs and what international patients should prepare.

Edward YEUNG

9/16/20269 min read

A diagnosis of tonsil cancer can lead to very different treatment plans.

Some patients may receive radiotherapy as their main treatment. Others may first undergo surgery to remove the tumor and affected lymph nodes, followed by several weeks of postoperative radiotherapy.

To show how different these treatment journeys can be, this article looks at two patients treated in China.

The first was a 65-year-old American living in Shenzhen who received radiotherapy after being diagnosed with right tonsil cancer with cervical lymph-node involvement.

The second was a Chinese patient treated in Shanghai who underwent extensive surgery followed by 33 sessions of postoperative radiotherapy.

These cases should not be interpreted as treatment recommendations. Their value is in showing what the real treatment process can look like—and why tonsil cancer care needs to be individualized.

What Is Tonsil Cancer?

The tonsils are part of the oropharynx, the middle part of the throat. Tonsil cancer is therefore generally classified as a type of oropharyngeal cancer.

Symptoms can initially look relatively harmless. Possible signs include a persistent sore throat, difficulty or pain when swallowing, a mouth or throat lesion that does not heal, ear pain, or a lump in the neck. Many of these symptoms can also be caused by non-cancerous conditions, but persistent symptoms should be medically evaluated.

Diagnosis normally requires a biopsy. Depending on the situation, doctors may also use MRI, contrast CT, PET-CT, endoscopy or laryngoscopy to determine the extent of the disease. Oropharyngeal tumors are also commonly tested for p16, which is used as a marker related to HPV status and plays an important role in staging and prognosis.

Case 1: An American Patient Chooses Radiotherapy in Shenzhen

A 65-year-old American man had lived in Shenzhen for around 20 years.

Beginning in the second half of 2025, he noticed persistent discomfort in his mouth. At first, the problem appeared similar to an oral ulcer.

When the lesion did not resolve, he visited two private clinics. After further evaluation, he was advised to attend a comprehensive hospital.

At Southern Medical University Shenzhen Hospital, he was diagnosed with right tonsil cancer with cervical lymph-node metastasis, according to the hospital's published account.

His doctors initially discussed treatment involving radiotherapy and chemotherapy.

However, the patient was strongly concerned about chemotherapy because he had witnessed a family member experience significant side effects during cancer treatment.

After discussing his concerns with the oncology team, he proceeded with a radiotherapy-based treatment plan.

Five weeks of radiotherapy

According to the hospital, the patient's schedule was intensified from the usual five treatment days per week to:

6 radiotherapy sessions per week

for approximately:

5 weeks

This resembles an altered or accelerated fractionation approach, in which radiation treatments are delivered over a shorter overall period.

Altered-fractionation radiotherapy is one of several recognized treatment approaches for selected patients with oropharyngeal cancer. For locally advanced disease, other options can include concurrent chemoradiotherapy or surgery followed by postoperative treatment.

The original hospital article did not provide the patient's complete TNM stage, pathology subtype, p16 status, radiation dose or specific radiation technology.

Those details are important, so this individual case should not be interpreted as evidence that radiotherapy alone is appropriate for other patients with tonsil cancer.

The hospital reported disappearance of the visible tumor

After approximately five weeks of treatment, the hospital reported that the patient's tumor was no longer detectable.

However, the publication did not provide long-term follow-up information, so it would be inappropriate to describe this result as a confirmed long-term cure.

The patient continued follow-up after completing treatment.

The Difficult Part: Radiation-Induced Oral Mucositis

Although the treatment response was encouraging, the patient developed severe side effects.

The most significant problem described by the hospital was oral mucositis.

His mouth and throat became so painful that eating solid food became extremely difficult. For about a month, he relied heavily on intravenous and nutritional support.

This is an important part of the story because head-and-neck radiotherapy can affect much more than the tumor itself.

Radiation to the head and neck can cause:

  • oral inflammation and ulceration,

  • throat and mouth pain,

  • dry mouth,

  • taste changes,

  • difficulty swallowing,

  • infection risk,

  • nutritional problems,

  • and, in some patients, longer-term tissue or salivary-gland damage.

This means that successful head-and-neck cancer treatment is not only about delivering radiation. Nutrition, oral care, pain control and management of treatment complications can become an important part of the medical journey.

Case 2: Surgery Followed by 33 Radiotherapy Sessions in Shanghai

The second patient followed a very different treatment pathway.

The patient reported having throat pain for approximately 10 months before tonsil cancer was finally diagnosed.

According to the patient's own account:

  • an MRI on April 17 first identified the suspected tonsil cancer,

  • biopsy results on April 27 confirmed the diagnosis,

  • and the tumor was reported as p16-negative.

The patient consulted specialists in medical oncology, head-and-neck surgery and radiotherapy before deciding to proceed with surgery.

A 7.5-Hour Operation

The patient was admitted to Huashan Hospital in Shanghai on May 6.

On May 7, the patient underwent an operation lasting approximately 7.5 hours.

According to the patient's description, surgery included:

  • extended removal of the tonsillar tumor,

  • removal of approximately one-quarter of the tongue base,

  • and a cervical lymph-node dissection.

The patient later reported that postoperative pathology found:

one metastatic lymph node

as well as:

nerve invasion

The full pathology report was not published, so the exact pathological stage and detailed risk features cannot be independently determined from the patient's account.

Recovery After Surgery

The postoperative period was difficult.

The patient described waking in intensive care with:

  • multiple neck drains,

  • a feeding tube passing through the nose,

  • severe oral and throat pain,

  • significant difficulty swallowing,

  • heavy secretions,

  • difficulty clearing mucus,

  • and extensive monitoring.

Approximately two days were spent in intensive care, followed by several days in a higher-dependency ward before transfer to a standard inpatient room.

Because swallowing was severely impaired, nutrition was initially delivered through a nasogastric feeding tube.

The patient was discharged around 12 days after surgery, but recovery continued at home.

The feeding tube remained particularly uncomfortable and was eventually removed approximately one month later.

This highlights an important consideration for international patients: major head-and-neck cancer surgery can involve considerably more than the operation itself.

Patients may need time for:

swallowing recovery, nutrition support, wound care, rehabilitation and postoperative pathology review

before the next stage of treatment even begins.

Why Was Radiotherapy Still Needed After Surgery?

About one week after surgery, the patient's final pathology results showed lymph-node metastasis and nerve involvement.

Doctors therefore recommended postoperative radiotherapy.

Radiation can be used after surgery to reduce the risk of cancer returning when doctors believe microscopic cancer cells could remain or when pathological findings indicate a higher recurrence risk. Depending on the pathological findings, postoperative treatment may involve radiation alone or combined chemoradiotherapy.

The patient underwent:

Radiotherapy planning: May 26

followed by additional CT-related planning on: June 9

and began radiotherapy on: June 16

The full course consisted of: 33 radiotherapy sessions

over approximately seven weeks.

What Did 33 Sessions of Head-and-Neck Radiotherapy Feel Like?

One particularly useful part of this patient's account is the detailed week-by-week description.

Week 1: Sessions 1–5

The patient reported few significant side effects initially.

By the second session, some nausea had developed.

Food was mainly soft or liquid, supplemented with nutritional products.

Week 2: Sessions 6–10

Nausea continued.

The patient increasingly relied on foods such as steamed egg, porridge and nutritional drinks.

Week 3: Sessions 11–15

The experience changed significantly.

The patient reported:

  • severe throat pain,

  • beginning oral ulceration,

  • and difficulty swallowing.

Week 4: Sessions 16–20

Oral mucositis worsened.

The patient also developed low-grade fever and coughing. A CT scan reportedly showed mild pneumonia.

Treatment and nutritional support were required during this period.

Week 5: Sessions 21–25

Oral symptoms continued, and supportive treatment remained an important part of care.

Week 6: Sessions 26–30

Radiation-related skin changes became more obvious.

The patient reported:

  • darkening of the skin around the neck,

  • itching,

  • worsening mouth ulcers,

  • and severe ulceration near the tongue base.

Week 7: Sessions 31–33

During the final three sessions, several treatment effects overlapped.

The patient nevertheless completed all 33 sessions.

The Week After Radiotherapy Was the Hardest

Interestingly, the patient reported that the worst period did not occur on the final treatment day.

Instead, symptoms peaked during the first week after radiotherapy ended.

The patient described:

  • severe oral ulcers,

  • tongue-base pain,

  • large amounts of mucus,

  • darkened neck skin,

  • and a pulling sensation around the neck.

During the second week after treatment, symptoms began to improve.

By approximately 27 days after completing radiotherapy, most major symptoms had improved considerably, although appetite had not fully returned.

This delayed peak in symptoms is an important practical point for patients travelling for treatment: finishing the last radiation session does not necessarily mean that the patient is immediately ready to travel home.

Two Tonsil Cancer Patients, Two Very Different Treatments

These two cases illustrate why there is no single treatment pathway for tonsil cancer.

Patient 1 — Shenzhen

Right tonsil cancer + cervical lymph-node involvement

Treatment:

  • Radiotherapy as the main treatment

  • Approximately 5 weeks

  • 6 sessions per week

Patient 2 — Shanghai

Tonsil cancer + lymph-node metastasis

Treatment:

  • Major surgery

  • Tonsil tumor resection

  • Partial tongue-base resection

  • Neck dissection

  • Followed by 33 sessions of postoperative radiotherapy

Why the difference?

Treatment decisions for oropharyngeal cancer can depend on:

  • tumor stage,

  • tumor size and location,

  • lymph-node involvement,

  • whether the tumor is p16/HPV-positive or negative,

  • surgical feasibility,

  • expected swallowing and speech outcomes,

  • pathology after surgery,

  • the patient's general health,

  • and the patient's preferences.

For early-stage disease, surgery or radiation can both be treatment options in appropriate patients. For more advanced disease, treatment may involve chemoradiotherapy or surgery followed by radiation or chemoradiotherapy.

The important lesson is not that one approach is better.

It is that two patients with “tonsil cancer” may need completely different treatment plans.

How Much Can Tonsil Cancer Treatment Cost in China?

There is no single price for tonsil cancer treatment in China.

Costs depend on factors such as:

  • hospital,

  • city,

  • surgery complexity,

  • length of hospitalization,

  • ICU use,

  • pathology,

  • radiation technique,

  • number of radiation sessions,

  • chemotherapy if required,

  • imaging,

  • nutrition,

  • and management of complications.

However, the second patient provided an unusually useful real-world cost reference.

According to the patient's own account:

Surgery and hospitalization: Around RMB 60,000

Radiotherapy: More than RMB 90,000

PET and other outpatient examinations: More than RMB 10,000

Approximate total: RMB 160,000+

These figures are not an official hospital quotation and have not been independently verified from invoices.

They should be treated as one patient's experience, not as the standard price of tonsil cancer treatment in China.

The first American patient's hospital article did not disclose his treatment costs.

For an international patient, actual charges may also differ depending on whether treatment is provided through a standard public-hospital service, a special medical service or an international medical department.

What Should an Overseas Patient Prepare Before Asking a Chinese Hospital for an Opinion?

For a patient already diagnosed with tonsil or oropharyngeal cancer, simply sending a short diagnosis usually is not enough for a specialist to make a meaningful assessment.

Useful records may include:

Pathology

  • biopsy report,

  • pathology slides if available,

  • p16/HPV testing results.

Imaging

  • contrast CT,

  • MRI,

  • PET-CT if already performed,

  • original DICOM imaging files rather than screenshots alone.

Clinical information

  • current symptoms,

  • previous surgery records,

  • existing treatment recommendations,

  • medication list,

  • other medical conditions.

Because biopsy confirmation, p16 testing and imaging such as CT, MRI and PET-CT can all contribute to staging and treatment planning, these records can materially affect what treatment a specialist recommends.

Why a Second Specialist Review Can Matter

The two cases in this article also demonstrate why complex cancer cases sometimes benefit from review by more than one specialty.

A patient may need input from:

  • head-and-neck surgery

  • radiation oncology

  • medical oncology

  • radiology

  • pathology

  • nutrition

  • rehabilitation

The second patient specifically described consulting several different specialists before deciding on surgery.

For an overseas patient considering travelling to China, obtaining a specialist review before booking flights may help answer questions such as:

  • Is surgery technically possible?

  • Is radiotherapy more appropriate?

  • Would treatment require chemotherapy as well?

  • How long might the patient need to remain in China?

  • What additional tests would be required after arrival?

A remote review cannot replace an in-person examination, but it can help determine whether travelling for further assessment is reasonable.

How Long Might a Patient Need to Stay in China?

This is one of the most important practical questions for medical travellers.

The second patient's experience shows why treatment can require a substantial stay.

His timeline included:

  • surgery and approximately 12 days in hospital

  • several additional weeks of surgical recovery

  • radiotherapy planning

  • approximately seven weeks of radiotherapy

  • continued recovery after the final session

An overseas patient requiring both surgery and radiotherapy therefore may need to plan for several weeks or potentially months, rather than a short medical trip.

The exact timeline varies significantly from patient to patient.

The Human Side of Head-and-Neck Cancer Treatment

Both cases have something else in common.

The hardest part was not simply choosing a hospital or completing the technical treatment.

Both patients experienced periods when eating became extremely difficult.

Both required significant support during treatment.

For international patients, these problems can be even harder when they are:

  • in a foreign country,

  • unable to speak Chinese,

  • physically weak,

  • attending hospital repeatedly,

  • and trying to understand a complex treatment plan at the same time.

That is why medical travel for cancer is fundamentally different from simply booking a doctor's appointment.

Getting Treatment in China With China MedCare

China MedCare helps international patients navigate medical care in China.

For complex conditions such as cancer, our role is not to diagnose the disease or decide which treatment a patient should receive.

Instead, we can help with the practical parts of the journey:

  • identifying relevant hospitals and specialists,

  • organizing medical records,

  • coordinating appointments,

  • communicating with hospitals,

  • planning the medical visit,

  • English-language support,

  • and in-person medical concierge assistance in Shenzhen.

For patients considering treatment in China, the first step is usually to send existing medical records so that we can understand what type of specialist or hospital may be appropriate.

Final Takeaway

These two real-world cases show how different tonsil cancer treatment can be.

One patient received approximately five weeks of radiotherapy without surgery.

Another underwent major surgery followed by 33 radiotherapy sessions.

Both experienced significant side effects from treatment, particularly oral and throat problems.

The second patient reported total treatment-related costs exceeding RMB 160,000, although this was an individual experience rather than an official hospital price.

For an international patient, the most important step is therefore not simply finding “the cheapest cancer treatment in China.”

It is obtaining a proper specialist assessment, understanding the likely treatment pathway, estimating how long treatment may take, and planning for the support that may be needed throughout the process.

Case-source note: The first case is based on a patient story published by Southern Medical University Shenzhen Hospital. The second is based on an individual patient's publicly shared treatment experience. Patient-reported experiences do not establish that the same treatment or outcome will apply to other patients.

Medical disclaimer: This article is for general informational purposes only and does not provide medical advice. Tonsil and oropharyngeal cancer treatment depends on pathology, stage, HPV/p16 status, overall health and other individual factors. Treatment decisions should be made with qualified oncology specialists.

© 2026 China Medcare. All rights reserved.

Contact:

info@china-medcare.com

+852 9548 6941